APYX Earnings & Financial Statements
Apyx Medical Corporation
$2.49
+$0.13(+5.30%)
36
Overall
40
Value
18
Tech
50
Quality
Market Cap
$99.41M
Volume
57.91K
52W Range
$2.32 - $5.08
Target Price
$6.50
APYX earnings and financial statements: Apyx Medical Corporation's income statement, balance sheet and cash flow statement, annual and quarterly.
APYX Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $52.84M | $48.10M | $52.35M | $44.51M | $48.52M |
| Cost of revenue | $19.80M | $18.74M | $18.59M | $15.38M | $14.92M |
| Operating income | -$6.45M | -$18.84M | -$17.26M | -$23.56M | -$14.45M |
| EBITDA | -$4.59M | -$16.80M | -$20.59M | -$22.01M | -$13.91M |
| Net income | -$11.21M | -$23.46M | -$18.71M | -$23.18M | -$15.17M |
| EPS (diluted) | $-0.27 | $-0.66 | $-0.54 | $-0.67 | $-0.44 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $66.84M | $64.84M | $79.24M | $51.77M | $68.72M |
| Total liabilities | $52.01M | $50.51M | $52.32M | $13.98M | $14.71M |
| Shareholders’ equity | $14.54M | $14.21M | $26.70M | $37.58M | $53.70M |
| Cash and equivalents | $31.74M | $31.74M | $43.65M | $10.19M | $30.87M |
| Long-term debt | $38.91M | $38.41M | $38.13M | $543.0K | $18.0K |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | -$8.00M | -$18.05M | -$5.25M | -$20.28M | -$10.45M |
| Capital expenditure | -$1.11M | -$722.0K | -$533.0K | -$1.01M | -$723.0K |
| Free cash flow | -$9.12M | -$18.77M | -$5.78M | -$21.29M | -$11.17M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | APYX | $2.49 | +5.3% | 57.91K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Apyx Medical Corporation Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW